Why Orgenesis (ORGS) Stock Is Down 23% Today
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 23 2024
0mins
Source: Benzinga
Stock Performance and Reverse Split: Orgenesis Inc (ORGS) shares fell 21% to 40 cents after announcing a 1-for-10 reverse stock split, effective September 24, to meet Nasdaq's $1.00 minimum bid price requirement, reducing outstanding shares from 47.7 million to approximately 4.77 million.
Investment Considerations: The stock has decreased by 29.34% over the past year and 37.67% in the last month, with an all-time high of $5.02 indicating significant potential upside from current levels, but investors should evaluate their time horizon and unrealized gains before making decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
